@article{JTD31310,
author = {Min P. Kim and Stephen G. Swisher},
title = {Heterogeneity of stage IIIA leads to difficulty in determining optimal treatment},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 15},
year = {2019},
keywords = {},
abstract = {A recent PACIFIC trial shows that patients with clinical stage IIIA non-small cell lung cancer who can’t have surgical resection have an overall survival rate of 66% at 24 months with chemoradiation therapy followed by immunotherapy.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/31310}
}